Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | CDK1 | P06493 | 1/20 | 0.53 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.42 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20315376 | 0.91 | GAA (0.65) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL8325931 | 0.91 | GAA (0.65) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL5793535 | 0.91 | GAA (0.65) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL12418558 | 0.88 | CA2 (0.50) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL12508190 | 0.88 | CA2 (0.50) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL13424104 | 0.88 | CA2 (0.50) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL24211470 | 0.87 | CD209 (0.53) | GAACDK1CCNB1ACHECD209 | |
| SCHEMBL20225969 | 0.87 | GAA (0.42) | GAACDK1CCNB1ACHECA2 | |
| Melibiose SCHEMBL29542815 | 0.86 | GAA (0.59) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL11892651 | 0.86 | GAA (0.59) | GAACDK1CCNB1ACHEL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090264496-A1 | Compounds, Compositions and Methods for Making the Same | SIGNUM BIOSCIENCES, INC. | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264496-A1 | Compounds, Compositions and Methods for Making the Same | PPP2CA, PPP4C, PPP6C | GAA 3117/4885CDK1 229/4885CCNB1 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.